HS248
/ Zhejiang Hisun Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 08, 2023
A Study of HS248 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Hanhui Pharmaceutical Co., Ltd
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1